William R. Markesbery, MD, University of Kentucky
Affiliations: | Pathology | University of Kentucky, Lexington, KY |
Area:
neurology, oxidative stress, Alzheimer diseaseWebsite:
http://www.research.uky.edu/odyssey/spring10/markesbery.htmlGoogle:
"William Markesbery"Bio:
http://www.biomedexperts.com/Profile.bme/887009/William_R_Markesbery
http://uknow.uky.edu/node/6828
http://www.legacy.com/obituaries/kentucky/obituary.aspx?n=william-r-markesbery&pid=139242028
http://www.ukalumni.net/s/1052/index-no-right.aspx?sid=1052&gid=1&pgid=874
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=24
Cross-listing: Neurotree - Neuropathology Tree
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Iacono D, Zandi P, Gross M, et al. (2015) APOε2 and education in cognitively normal older subjects with high levels of AD pathology at autopsy: findings from the Nun Study. Oncotarget. 6: 14082-91 |
| Gwon AR, Park JS, Arumugam TV, et al. (2012) Oxidative lipid modification of nicastrin enhances amyloidogenic γ-secretase activity in Alzheimer's disease. Aging Cell. 11: 559-68 |
| Poon LW, Woodard JL, Stephen Miller L, et al. (2012) Understanding dementia prevalence among centenarians. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 67: 358-65 |
| Ding Q, Zhu H, Zhang B, et al. (2012) Increased 5S rRNA oxidation in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 29: 201-9 |
| Bradley MA, Xiong-Fister S, Markesbery WR, et al. (2012) Elevated 4-hydroxyhexenal in Alzheimer's disease (AD) progression. Neurobiology of Aging. 33: 1034-44 |
| Gleichmann M, Zhang Y, Wood WH, et al. (2012) Molecular changes in brain aging and Alzheimer's disease are mirrored in experimentally silenced cortical neuron networks. Neurobiology of Aging. 33: 205.e1-18 |
| Robinson RA, Joshi G, Huang Q, et al. (2011) Proteomic analysis of brain proteins in APP/PS-1 human double mutant knock-in mice with increasing amyloid β-peptide deposition: insights into the effects of in vivo treatment with N-acetylcysteine as a potential therapeutic intervention in mild cognitive impairment and Alzheimer's disease. Proteomics. 11: 4243-56 |
| Sultana R, Robinson RA, Di Domenico F, et al. (2011) Proteomic identification of specifically carbonylated brain proteins in APP(NLh)/APP(NLh) × PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice model of Alzheimer disease as a function of age. Journal of Proteomics. 74: 2430-40 |
| Aluise CD, Robinson RA, Cai J, et al. (2011) Redox proteomics analysis of brains from subjects with amnestic mild cognitive impairment compared to brains from subjects with preclinical Alzheimer's disease: insights into memory loss in MCI. Journal of Alzheimer's Disease : Jad. 23: 257-69 |
| Kramer PL, Xu H, Woltjer RL, et al. (2011) Alzheimer disease pathology in cognitively healthy elderly: a genome-wide study. Neurobiology of Aging. 32: 2113-22 |